Neteera

Neteera develops a contactless remote patient monitoring platform that uses high-frequency radar technology to continuously track vital signs without wearables, cameras, or physical contact. The ceiling- or wall-mounted sensor detects subtle skin movements from heartbeat and breathing through clothing and bedding, measuring heart rate, respiratory rate, sleep patterns, motion, position changes, and exit detection. AI-driven health insights are delivered to a centralized dashboard, enabling early detection of patient decline with up to 89% treat-in-place rates and an average of one day advance notice before deterioration. The system serves health systems, medical groups, payers, post-acute care facilities, senior living communities, and service providers, with over 525 healthcare deployments and 38,975+ devices in use. The company holds FDA 510(k) Class II clearance and ISO/IEC 27001 certification. Founded in 2014 and headquartered in Jerusalem, Israel, Neteera has raised $28.2M in Series B funding from investors including Aescuvest, Foxconn Electronics, and Omega Healthcare Investors.